CYP3A4 association with NAFLD was also studied by Powell et al. They performed RNA-seq analysis for 93 liver tissue samples and found that CYP3A4 expression was not significantly downregulated in NAFLD, NASH, and fibrosis samples. The gene discussed is CYP3A4; the disease is metabolic dysfunction-associated steatotic liver disease.